Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03200626 · ClinicalTrials.gov registry record
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 750
- Enrollment target
NCT03200626 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 750 participants.
The verdict
NCT03200626 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.
Interventions
- PROCEDURE Autologous hematopoietic cell transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2022-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03200626
The ClinicalTrials.gov registry entry for NCT03200626 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autologous hematopoietic cell transplant is the first listed.
NCT03200626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03200626 about?
NCT03200626 is a clinical study titled "Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma". Prospective, multicenter, observational registry of myeloma patients undergoing hematopoietic progenitor cell mobilization for upfront autologous transplantation.
What is the current status of trial NCT03200626?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2017-06-01. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT03200626?
The interventions under investigation include: Autologous hematopoietic cell transplant (PROCEDURE).
Who is sponsoring clinical trial NCT03200626?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.